Flinn
Flinn is an AI-powered SaaS platform that automates regulatory and quality compliance workflows for medical device manufacturers and pharmaceutical companies, serving over 100 MedTech customers across 14+ countries with modules for safety database monitoring, literature evaluation, regulatory monitoring, and complaint handling.
- Company typePrivate
- Founded2022
- HeadquartersVienna, Austria
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Flinn does
Flinn (legally 1BillionLives GmbH) is an AI-driven SaaS platform that automates regulatory and quality compliance processes for medical device manufacturers (MedTech) and pharmaceutical companies operating under EU MDR/IVDR and adjacent regulatory regimes. Founded in Vienna in 2022 by former N26 employees, the company sells a unified platform with five core modules — Safety Database Monitoring, Literature Evaluation, Regulatory Monitoring, Complaint Handling, and Vigilance — built on NLP, machine learning, and large language models that are fine-tuned on curated medical corpora and validated under IEC 62304 and ISO 13485. Flinn 3.0 (Nov 2025) added Clinical Writing, Citation management, and a Literature Library, and integrations with Mira.Digital (literature procurement) and Siemens Polarion (via avasis) extend the platform into adjacent enterprise systems.
The company serves a vertically segmented customer base spanning small and medium MedTech manufacturers (5–100 Technical Files) up through large enterprises with thousands of Technical Files, including named customers such as Erbe Elektromedizin, Skan AG, and Medi GmbH across 14+ countries in Europe and North America. Pricing is quote-based annual subscription, tiered by portfolio size and module selection, with a free demo / evaluation period reducing sales friction for smaller customers. Distribution is direct enterprise field sales supplemented by inside sales for mid-market and self-serve evaluation for smaller accounts, supported by a strategic advisor network of former executives from Siemens Healthineers, ResMed, Smith & Nephew, and DentsplySirona.
Flinn has raised approximately $30 million cumulatively across a December 2022 pre-seed (€1.8M, Speedinvest and SquareOne), a September 2024 seed (€10M, Cherry Ventures led), and a February 2026 Series A ($20M, HV Capital led with Bertelsmann Healthcare Investments and existing investors participating). The Series A is explicitly directed at US market entry and lifecycle expansion. The company operates from three offices (Vienna HQ, Berlin, Paris) with a headcount in the 11–50 band and is led by co-founders Bastian Krapinger-Rüther, Hasib Samad, and Markus Müller.
Flinn firmographics
Firmographics- Name
- Flinn
- Legal name
- 1BillionLives GmbH
- Website
- https://flinn.ai
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Flinn is an AI-powered SaaS platform that automates regulatory and quality compliance workflows for medical device manufacturers and pharmaceutical companies, serving over 100 MedTech customers across 14+ countries with modules for safety database monitoring, literature evaluation, regulatory monitoring, and complaint handling.
- Ownership category
- akta.pro rank
Flinn industry classification
Industry- Product category
- MedTech Regulatory Compliance Software
- NAICS
- Scientific Research and Development Services (5417), Computer Systems Design and Related Services (54151)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Pharmacovigilance & Drug Safety Software (HLAGAJAK)
- akta.pro secondary industries
- Regulatory Affairs & Submissions FSP (HLAGAOAD), Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN)
Keywords
Where Flinn is headquartered
LocationHeadquarters
- HQ city
- Vienna
- HQ country
- Austria
- HQ region
- Europe
Offices3 records
Markets served
Flinn business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- SaaS Subscription: Cloud-based software subscription model providing access to the Flinn compliance platform, with modules for literature evaluation, safety database monitoring, regulatory monitoring, complaint handling, and vigilance management. Pricing is likely tiered based on portfolio size and number of modules.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise tier for large MedTech manufacturers |
| Subscription | Annual | SME/Mid-market tier |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Flinn product offering
Product offeringCore offering
Flinn provides an AI-driven SaaS platform that automates regulatory and quality processes for medical device (MedTech) and pharmaceutical manufacturers. Its modular suite covers safety database monitoring, literature evaluation, regulatory change monitoring, complaint handling, and vigilance management, with full validation documentation compliant to IEC 62304, ISO 13485, ISO 27001, EU AI Act, and FDA 21 CFR Part 11. The platform serves over 100 MedTech leaders across 14 countries, processing 40+ million publications and 20+ million incident reports.
Product overview
Flinn is an AI-driven platform for automating regulatory and quality processes in MedTech and Pharma. The platform follows a unified architecture with a core AI engine supporting multiple integrated modules: Safety Database Monitoring (vigilance), Literature Evaluation, Regulatory Monitoring, Complaint Handling, and a Vigilance Module. Flinn 3.0 introduced Clinical Writing, Citation, and Literature Library as sub-features. The platform automates workflows across the entire medical product lifecycle including post-market surveillance, literature reviews, regulatory compliance, and complaint management. Additional capabilities include a Word Plugin for document generation and API integrations with third-party systems like Polarion.
Differentiator
Problem solved
Functional benefit
Products and services
- Safety Database Monitoring AI-powered module that automates adverse event and safety database monitoring across 15+ global databases including FDA MAUDE, BfArM, and SwissMedic, with real-time vigilance surveillance, smart grouping of reports, automated de-duplication, and 1-click audit-ready report generation. Built for MedTech and pharmaceutical manufacturers under MDR/IVDR.
- Literature Evaluation AI-assisted literature search and screening module for systematic reviews, state-of-the-art searches, and PMCF/PMPF literature evaluation. Features multi-database search across 40+ million publications, human study detection with 99% precision, and integration with Mira.Digital for embedded literature purchasing.
- Regulatory Monitoring Module for monitoring and analyzing global regulatory changes and standards updates. Tracks changes to MDR, IVDR, FDA requirements, and other standards, with delta and impact analysis for regulatory compliance.
- Complaint Handling Module for managing complaint data intake, evaluation, and processing. Supports structured complaint workflows, intelligent categorization, and integration with risk management systems for MedTech compliance.
- Vigilance Module Comprehensive post-market surveillance module supporting PMS/PSUR reporting, PMCF/PMPF follow-up activities, and safety signal detection. Features automated monitoring, evaluation workflows, and audit-ready documentation with >80% faster vigilance processes versus traditional methods.
- Flinn Word Plugin Microsoft Word integration enabling direct literature report generation, citation management, and document writing within Word for regulatory and clinical writing teams.
Quantifiable outcome
- Complete vigilance process >80% faster than traditional methods
- +5 more outcomes
Companies that use Flinn
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
Flinn technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability8 records
Feature8 records
Flinn partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered supporting and core.
- avasis solutions GmbHsupportingAPI integration partnership connecting Flinn with Siemens Polarion for streamlined MedTech regulatory workflows, enabling data exchange between quality management and regulatory compliance systems.
- MIRA.Digital GmbHcoreIntegration partnership for literature procurement and license handling. Mira provides embedded purchasing and license management for scientific publications within Flinn's Literature Module, covering 99.9% of scientific publications worldwide with validated licensing compliance.
- qtec Services GmbHcoreStrategic partnership providing MDR-compliant support in risk management, clinical evaluation, and regulatory affairs. qtec complements Flinn's platform with specialized consulting services throughout the medical device product lifecycle.
Scale indicators10 records
Recent moves6 records
Expansion highlights7 records
Flinn competitors and assessment
Company assessmentDirect peers
- Greenlight Guru: MedTech-focused quality management and regulatory compliance SaaS offering eQMS, CAPA, design controls, and document management — directly competes with Flinn's regulatory/quality automation platform for medical device manufacturers.
- MasterControl: Established QMS and regulatory compliance platform purpose-built for life sciences and MedTech, offering validated software for document control, training, and quality processes — overlaps with Flinn's validated compliance modules.
- Rimsys: Regulatory information management platform purpose-built for medical device companies, covering submissions, registrations, standards, and global regulatory intelligence — closely mirrors Flinn's regulatory monitoring and submissions support.
- Dot Compliance: AI-enabled QMS solution for MedTech and pharma covering complaints, CAPA, audits, and training — direct competitor in the AI-powered MedTech compliance category.
- Kneat: Digital validation lifecycle management SaaS for life sciences, used for equipment, computer system, and process validation — comparable to Flinn on the regulated validation/documentation layer of MedTech workflows.
- ArisGlobal: Life sciences regulatory technology platform covering regulatory information management, pharmacovigilance, and safety — overlaps with Flinn's vigilance and regulatory monitoring modules for pharma and MedTech.
- Schlafender Hase: Regulatory document validation and text-comparison software widely used in pharma/MedTech regulatory affairs — comparable to Flinn on regulatory submission accuracy and document proofreading use cases.
- AssurX: Regulated quality management software for life sciences including complaints, CAPA, change control, and audits — overlaps with Flinn's complaint handling and regulatory workflow automation.
Broad incumbents
- Veeva Systems: Large incumbent cloud software provider for life sciences with Vault RIM, Vault QMS, and safety modules — broader portfolio than Flinn but competes on regulatory document and quality management for MedTech/pharma.
- IQVIA: Global CRO and life sciences technology provider with regulatory affairs, safety/pharmacovigilance, and RWE services — competes indirectly through its tech-enabled regulatory and safety offerings for MedTech manufacturers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Flinn social profiles
Digital presenceFlinn compliance and trust
Trust signalCompliance7 records
Flinn financial estimates
Financial estimateRevenue estimate
Valuation estimate
Flinn leadership team
Management profileNumber of profiles
Profiles5 records
Flinn funding detail
Funding detailFunding overview
Funding rounds5 records
Investors7 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Flinn M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Flinn
What does Flinn do?
Flinn provides an AI-driven SaaS platform that automates regulatory and quality processes for medical device (MedTech) and pharmaceutical manufacturers. Its modular suite covers safety database monitoring, literature evaluation, regulatory change monitoring, complaint handling, and vigilance management, with full validation documentation compliant to IEC 62304, ISO 13485, ISO 27001, EU AI Act, and FDA 21 CFR Part 11. The platform serves over 100 MedTech leaders across 14 countries, processing 40+ million publications and 20+ million incident reports.
Is Flinn a public or private company?
Flinn is a private company. It is classified as venture growth investor backed and is currently operating.
When was Flinn founded?
Flinn was founded in 2022. It employs 11 to 50 people.
Where is Flinn based?
Flinn is headquartered in Vienna, Austria, in the Europe region.
How does Flinn make money?
One revenue line is on record: saaS Subscription.
Who are Flinn's main competitors?
Direct peers on record are Greenlight Guru, MasterControl, Rimsys, Dot Compliance, Kneat, ArisGlobal, Schlafender Hase and AssurX. Broad incumbents are Veeva Systems and IQVIA.
Does Flinn have an API?
Yes. Flinn offers an API integration that connects with Polarion via avasis solutions GmbH partnership. This API integration enables interoperability between Flinn's regulatory and quality management platform and Polarion (a product lifecycle management software) for MedTech workflows.
What industry is Flinn in?
Flinn's product category is MedTech Regulatory Compliance Software. Its primary akta.pro industry code is HLAGAJAK, Pharmacovigilance & Drug Safety Software, with a secondary code of HLAGAOAD, Regulatory Affairs & Submissions FSP. Its NAICS code is 5417 and its SIC code is 8731.